AU2003249933A1 - Antiperspirant aerosol compositions - Google Patents

Antiperspirant aerosol compositions Download PDF

Info

Publication number
AU2003249933A1
AU2003249933A1 AU2003249933A AU2003249933A AU2003249933A1 AU 2003249933 A1 AU2003249933 A1 AU 2003249933A1 AU 2003249933 A AU2003249933 A AU 2003249933A AU 2003249933 A AU2003249933 A AU 2003249933A AU 2003249933 A1 AU2003249933 A1 AU 2003249933A1
Authority
AU
Australia
Prior art keywords
aach
aerosol composition
composition according
viscosity
oil
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU2003249933A
Other versions
AU2003249933B2 (en
Inventor
Nathan Charles Brown
Hugh Rieley
Thomas Edward Shearmur
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Unilever PLC
Original Assignee
Unilever PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9941089&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AU2003249933(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Unilever PLC filed Critical Unilever PLC
Publication of AU2003249933A1 publication Critical patent/AU2003249933A1/en
Application granted granted Critical
Publication of AU2003249933B2 publication Critical patent/AU2003249933B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04Dispersions; Emulsions
    • A61K8/046Aerosols; Foams
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/26Aluminium; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/89Polysiloxanes
    • A61K8/891Polysiloxanes saturated, e.g. dimethicone, phenyl trimethicone, C24-C28 methicone or stearyl dimethicone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q15/00Anti-perspirants or body deodorants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Dermatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Cosmetics (AREA)
  • Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

A suspension antiperspirant aerosol composition comprising milled activated aluminium chlorohydrate (AACH) having non-hollow particles and a carrier fluid comprising a masking oil of viscosity 10<SUP>3 </SUP>mm<SUP>2</SUP>/s or greater gives good antiperspirancey and reduced levels of white deposits.

Description

WO2004/014330 PCT/EP2003/007065 ANTIPERSPIRANT AEROSOL COMPOSITIONS This invention relates to antiperspirant aerosol 5 compositions suitable for topical application to the human body and to methods of making the same. Antiperspirant compositions suitable for topical application typically comprise an antiperspirant material such as 10 aluminium chlorohydrate which acts to suppress the level of perspiration on the area of the body to which it is applied. Antiperspirant compositions are widely applied in the form of a pressurised, propellant driven aerosol spray. 15 Aerosol antiperspirant compositions typically have the antiperspirant material suspended in an anhydrous carrier fluid, together with a propellant and a suspending agent. Other minor ingredients can also be present, and the composition is housed in a pressurised container. 20 A major problem associated with all antiperspirants, including aerosol antiperspirants, is that of deposition or whitening where the antiperspirant active, which is usually in powder form, is deposited on a user's clothes or skin, 25 thereby causing visible whitening/staining and occasionally damage to the clothes. Various attempts have been made to reduce the whitening or visible deposits. A widely used approach has been to 30 incorporate a masking oil such as an aliphatic hydrocarbon, ester oil, or silicone fluid into the formulation.
WO2004/014330 PCT/EP2003/007065 - 2 The masking oil functions by coating the surface of the antiperspirant active particles and minimises the scattering of light, thereby rendering the active less visible to the naked eye. 5 The masking method has been found to reduce whitening in stick and roll-on products. The reduction of whitening caused by aerosol compositions containing activated aluminium chlorohydrate (AACH) as the active is more 10 difficult. This is in part due to the difficulty in matching the refractive index (RI) of the masking oil with that of AACH, as commercially available AACH does not have a continuous RI value throughout the particle. More particularly, AACH particles generally contain hollow cores, 15 having an RI of 1.0 while the RI of the outer particle is in the region of 1.5 which results in visible whitening. One approach to reducing the whitening problem with AACH aerosol compositions is described in US 5,840,289 (Hall), 20 wherein the AACH is milled to reduce the number of particles having hollow cores and the resulting active is masked with a masking oil of appropriate RI. The inventors have now discovered that good antiperspirancy 25 and remarkably low whitening can be achieved with AACH aerosol compositions comprising milled AACH having non hollow particles in combination with a masking oil of particularly high viscosity. The good antiperspirancy found with compositions of the invention may enable a lower amount 30 of antiperspirant active to be used whilst still maintaining the antiperspirancy efficacy of a conventional aerosol WO2004/014330 PCT/EP2003/007065 -3 antiperspirant composition having a higher level of antiperspirant active. A further benefit that may be achieved by use of the present 5 invention is the enhanced maintenance of the antiperspirant active on the skin. This enables reduced transfer of the antiperspirant active to clothes worn in close proximity to the skin, thereby reducing whitening of said clothes and helps to maintain the antiperspirant benefit sought by the 10 consumer. Thus, according to a first aspect of the invention, there is provided a suspension antiperspirant aerosol composition comprising milled activated aluminium chlorohydrate having 15 non-hollow particles and a carrier fluid comprising a 3 2 masking oil of viscosity 10 mm2 Is or greater. According to a second aspect of the invention, there is provided a method of manufacture of a suspension 20 antiperspirant aerosol composition, said method comprising the suspension of a milled activated aluminium chlorohydrate (AACH) having non-hollow particles in a carrier fluid 3 2 comprising a masking oil of viscosity 10 mm2 Is or greater. 25 According to a third aspect of the invention, there is provided a method of reducing perspiration and giving low visible deposits comprising the application to the human body of a suspension antiperspirant aerosol composition comprising milled AACH having non-hollow particles and a WO 2004/014330 PCT/EP2003/007065 - 4 carrier fluid comprising a masking oil of viscosity 103 mm2/s or greater. Without wishing to be bound by theory, the applicant 5 believes that the reduced white deposits obtained with antiperspirant compositions of the present invention is due to the particular morphology of the antiperspirant actives selected and their highly effective coating by the particularly high viscosity masking oils indicated. 10 The chemical nature and preparation of AACH antiperspirant actives suitable for use in the present invention are described in GB 1,568,831, GB 1,597,497, GB 1,597,498, EP 6,738, EP 6,739, EP 7,191, EP 191,628, EP 256,832 and 15 EP 491,395, the contents of which are incorporated herein by reference. The amount of AACH present in the compositions of the invention may be from 1 to 30% and particularly from 2 to 20%, the upper level of AACH preferably being 10% or less and especially being 5% or.less, all percentages being 20 by weight of the composition. The AACH used in the present invention is milled and has non-hollow particles. Preferably, a high level of non hollow AACH particulate material is present, the hollows in 25 the particles comprising less than 40% of the total volume of the AACH. It is particularly preferred that the hollows comprise less than 20%, and especially less than 10%, of the total volume of the AACH. AACH in which hollows comprise less than 5% of the total volume of the active is most 30 preferred. Measurement of the amount of non-hollow AACH WO 2004/014330 PCT/EP2003/007065 - 5 particulate material may be performed by a suitable microscopy technique (e.g. SEM) in combination with suitable image analysis. 5 Suitably, the AACH used in the present invention has a continuous RI. The RI of the AACH is preferably between 1.52 to 1.57. The mean particle size of the AACH is preferably from 20 to 30 microns (measured as the D[4,3], using a light scattering technique). Typically the AACH is 10 prepared by milling a sample having a mean particle size (measured as above) of from 50 to 150 micron and comprising hollow particles. The masking oil used in the present invention has a 3 2 15 particularly high viscosity, being of viscosity 10 mm /s or greater. The viscosity values quoted in this specification are kinematic viscosities, measured at 25 0 C. A suitable method for measuring kinematic viscosities utilises a glass capillary viscometer, for example, as described in Dow 20 Corning's Corporate Test Method CTM 0004, of July 29, 1970. The masking oil may be any suitable oil of appropriate viscosity, examples including hydrocarbon oils, ester oils, and silicone oils. Suitable hydrocarbon oils include 25 hydrogenated polyolefins, in particular hydrogenated polydecenes, examples including PureSyn oils of viscosity 3 2 10 mm /s or greater, such as PureSyn 1000 or 3000, available from Exxon-Mobil. Suitable silicone oils include linear and crosslinked polydimethylsiloxane (PDMS) fluids, WO2004/014330 PCT/EP2003/007065 - 6 examples including the DC200 PDMS fluids of viscosity 103 2 mm /s or greater, available from Dow Corning. The RI of the masking oil is preferably from 1.40 to 1.57. 5 Silicone oils are particularly preferred. The viscosity of 3 2 4 2 the masking is 10 mm2 Is or greater, preferably 10 mm /s or greater, and more preferably 30,000 mm2/s or greater. The masking oil may be used in an amount from 0.5% or 1%, up 10 to 30%, in particular up to 10%, and especially up to 5%, all percentages being by weight of the total composition. The masking oil may function as an emollient oil and/or lubricant. It may also serve to facilitate uniform 15 distribution of the antiperspirant material on the skin. The carrier fluid is any oil suitable for suspending ACH and compatible with the masking oil comprising it. Typically, the carrier fluid is present at a level of from 1 to 30%, in 20 particular from 2 to 20%, and especially from 5 to 10% by weight of the composition. The carrier fluid may comprise an emollient oil, additional to any masking oil also having this function (vide supra). 25 Suitable emollient oils are disclosed in US Patent Nos. 4,822,596 and 4,904,463, the disclosures of which are incorporated by reference herein. Preferred emollient oils are alkyl esters, such as PurSyn Ester 2E7 (neopentylglycol dihexanoate), ex Exxon-Mobil; benzoate esters such as 30 Finsolv TN (Trade Mark), ex Finetex Inc.; hydrogenated WO 2004/014330 PCT/EP2003/007065 - 7 polyalkenes, such as Panalane, ex Amoco and PureSyn PAO 2 (hydrogenated polydecene), ex Exxon-Mobil; PPG ethers, such as Fluid AP (PPG-14 butylether), ex Union Carbide; isopropyl palmitate; phenylsilicone; and isopropyl myristate. 5 It is particularly preferred that the carrier fluid comprises a volatile silicone fluid. Preferred volatile fluids include dimethyl cyclosiloxanes, such Dow Corning fluids DC244, DC245, DC344 and DC345. The combination of 10 such materials and the masking oil may be used at a level of from 1 to 30%, in particular from 2 to 20%, and especially from 5 to 10% by weight of the composition. In order to prevent caking or settling out of the 15 antiperspirant salt from the carrier fluid, a bulking or suspending agent is preferably incorporated into the composition of the invention. The suspending agent is preferably hydrophobically treated montmorillionite clay such as a bentonite or a hectorite. One such commercially 20 available clay is Bentone 38V, which is a hectorite clay available from NL Industries, Inc. The amount of clay in the composition of the invention may be from 0.2 to 5.0% by weight of the total composition. 25 A propellant gas is generally present as part of the compositions of the invention. Any liquefiable gas known in the art for use in propellant driven aerosol products may be used. Examples of suitable propellants include trichlorofluoromethane, trichlorotrifluoromethane, 30 difluoroethane, propane, butane or isobutane or combinations thereof. When used, the amount of liquefied gas in the WO2004/014330 PCT/EP2003/007065 -8 composition of the invention is typically from 5 to 95% and preferably from 30 to 90% by weight of the composition. Alternatively, compressed gas such as air, nitrogen, or carbon dioxide may be used as propellant. 5 Other minor ingredients which may be present in the compositions of the invention include: - cosmetically acceptable carrier fluid components, such as straight and branched chain alcohols, for example, 10 ethanol, isobutanol or isopropanol; - deodorant active perfumes and deodorant compounds which can act as antimicrobial agents; - hydrophobic oils, such as liquid paraffin oils; - inorganic electrolytes, such as sodium chloride or sodium 15 sulphate; - other thickeners such as clays, silicas, for example, Aerosil 200 and hydroxypropyl celluloses such as Klucel; - polar additives such as propylene carbonate or alcohol; - skin feel improvers, such as talc and finely divided 20 polyethylene such as Accumist B18; - humectants, such as polyols, for example glycerol; - perfumes; - preservatives and antioxidants; - skin benefit agents such as allantoin; 25 - colours; - other cosmetic adjuncts conventionally employed in propellant driven aerosol products. The compositions of the invention may be manufactured by a 30 method comprising the suspension of a milled activated aluminium chlorohydrate (AACH) having non-hollow particles WO 2004/014330 PCT/EP2003/007065 -9 3 in a carrier fluid comprising a masking oil of viscosity 10 mm2/ Is or greater. Techniques employed in the manufacture of conventional suspension AP aerosol products may be employed. In a particular method of manufacture, the AACH is suspended 5 in a pre-formed mixture comprising volatile silicone, masking oil, and perfume, and said suspension is then placed in an aerosol can, preferably made of aluminium or tinplate, and a propellant gas is added in a liquefied form. 10 Examples The compositions indicated in the Tables below were prepared in the following manner. The volatile silicone, other oil 15 (silicone oil or hydrocarbon oil), and Bentone 38V where sheared together at 9000 rpm for 5 minutes using a Silverson L4RT mixer. The perfume was then added whilst shearing and shearing was continued for a further 2 minutes. Shearing was then discontinued and the AACH was dispersed in the 20 mixture using a spatula. The mixture was then subjected to a further 5 minutes shearing using the Silverson L4RT mixer. The whiteness scores were obtained using the following method. The fully formulated compositions were each sprayed 25 directly onto black test cloths from a distance of 25 cm, using a standard spray nozzle and a duration of 5 seconds per cloth. After approximately one hour, the whiteness scores of the cloths were measured using an image analysis technique. The results were analysed using standard WO 2004/014330 PCT/EP2003/007065 - 10 statistical techniques to give the average whiteness score from each composition and the 95% confidence limits. Comparative examples are indicated by letter codes. 5 Compositional amounts are given as percentages by weight. Table 1: Compositions comprising 3% masking oil 10 _IExamples _A B C 1 Components A2961 2 2 Alloxicol LR 2 - - 2 2 Bentone 38V 3 0.5 0.5 0.5 0.5 Volatile silicone 4 6.9 6.9 6.9 6.9 DC 200 (50)5 3
-
3 DC 200 (30,000) - 3 - 3 Fragrance 0.6 0.6 0.6 0.6 CAP 407 To 100 To 100 To 100 To 100 Whiteness Score: 1789 1397 1420 750 95% limits: ±145 ±89 ±64 ±57 1. Conventional unmilled AACH, ex BK Giulini. 2. Milled AACH, ex BK Giulini. 3. Suspending agent, hectorite clay, ex NL Industries. 4. DC245, ex Dow Corning. 15 5. PDMS of viscosity 50 mm2/s, ex Dow Corning. 6. PDMS of viscosity 30,000 mm2/s, ex Dow Corning. 7. Propellant, proprietary mix of butane, isobutane and propane, ex. Calor.
WO2004/014330 PCT/EP2003/007065 - 11 These results illustrate that use of a milled active having non-hollow particles (Alloxicol LR) and a masking oil having a particularly high viscosity (DC 200 (30,000 mm 2/s) leads to a particularly low whiteness score (Example 1). Poorer 5 (i.e. higher) whiteness scores where obtained when the composition comprised only one of the required features (Examples B and C) and an even poorer whiteness score was obtained when the composition comprised neither of the required features (Example A). 10 Table 2: Compositions comprising 1% masking oil Examples D 2 3 4 Components Alloxicol LR 1 2 2 2 2 Bentone 38V1 0.5 0.5 0.5 0.5 Bentone 38V Volatile silicone 8.92 8.9 8.9 8.9 DC 200 (50)1 1 - - DC 200 (1000)
-
1 11 DC 200 (30,000) - - 1 Puresyn 10004 - - 1 Fragrance 0.6 0.6 0.6 0.6 CAP 401 To 100 To 100 To 100 To 100 Whiteness Score: 1429 1213 848 1064 95% limits: ±123 +210 ±35 ±8 1. As defined in Table 1. 15 2. Including a small amount of silicone gum (Q2-1501, ex Dow Corning). 3. PDMS of viscosity 1,000 mm2/ s, ex Dow Corning.
WO 2004/014330 PCT/EP2003/007065 - 12 22 4. Hydrogenated polydecene of viscosity 42,300 mm2/ Is, ex Exxon-Mobil. These results illustrate the benefit of using a masking oil 3 2 5 of viscosity 10 mm2 Is or greater, whether the masking oil be a silicone oil or a hydrocarbon oil. The results from silicone oil containing Examples D, 2, and 3 are shown again in Figure 1, which suggests that a 10 logarithmic-linear relationship between viscosity and whiteness score may be present. Figure 1: relationship between PDMS viscosity and whiteness score 1500 1 4 0 0 .......... .................... . ............ .... ...
14 0 0................. . ......... ............ .............. 1300 .
y -91.195Ln(x) + 1805.6
R
2 = 0.9879 0 1200 S1100 1000 900 800 10 100 1000 10000 100000 Viscosity Im m 2s 15 Further Examples of compositions according to the invention are illustrated in Table 3.
WO2004/014330 PCT/EP2003/007065 - 13 Table 3 Examples 5 6 7 8 Components Alloxicol LR 1 2 2 2 2 Bentone 38V 1 0.5 0.5 0.5 0.5 Volatile silicone 9 - - Finsolv TN 2 - 8 - 8 PureSyn Ester 2E73 9 DC 200 (30,000) - - 1 0.5 PureSyn30004 1 1 - 0.5 PureSyn300____ Fragrance 0.6 0.6 0.6 0.6 CAP 401 To 100 To 100 To 100 To 100 1 As defined in Table 1. 5 2 C 12
-
15 alkyl benzoate, ex Finetex Inc. 3 Neopentylglycol dihexanoate, ex Exxon-Mobil. 4 Hydrogenated polydecene of viscosity 60,000 mm2/s, ex Exxon-Mobil.

Claims (11)

1. A suspension antiperspirant aerosol composition comprising milled activated aluminium chlorohydrate 5 (AACH) having non-hollow particles and a carrier fluid 3 2 comprising a masking oil of viscosity 10 mm /s or greater.
2. An aerosol composition according to claim 1, wherein 10 the AACH is present at a level of from 1% to 30% by weight of the composition.
3. An aerosol composition according to claim 2 wherein the AACH is present at a level of from 2% to 5% by weight 15 of the composition.
4. An aerosol composition according to any of the preceding claims, wherein the masking oil has a viscosity of 30,000 mm2/ Is or greater. 20
5. An aerosol composition according to any of the preceding claims, wherein the AACH has a continuous RI.
6. An aerosol composition according to any of the 25 preceding claims, wherein the masking oil has an RI of 1.40 to 1.57.
8. An aerosol composition according to claim 6, wherein the masking oil is a silicone oil. 30 WO2004/014330 PCT/EP2003/007065 - 15 9. An aerosol composition according to any of the preceding claims, comprising an additional emollient oil. 5 10. An aerosol composition according to any of the preceding claims, comprising a bulking or suspending agent.
11. An aerosol composition according to any of the 10 preceding claims, comprising a volatile silicone.
12. An aerosol composition according to any of the preceding claims, comprising a propellant gas. 15 13. An aerosol composition according to claim 12, wherein the propellant gas is a liquefied gas at a level of from 5 to 95% by weight of the composition.
14. A method of manufacture of a suspension antiperspirant 20 aerosol composition, said method comprising the suspension of a milled activated aluminium chlorohydrate (AACH) having non-hollow particles in a carrier fluid comprising a masking oil of viscosity 10 mm2/s or greater. 25
15. A method of reducing perspiration and giving low visible deposits comprising the application to the human body of a suspension antiperspirant aerosol composition comprising milled AACH having non-hollow 30 WO2004/014330 PCT/EP2003/007065 - 16 particles and a carrier fluid comprising a masking oil of viscosity 10 3 mm2s or greater. of viscosity 10~ mm /s or greater.
AU2003249933A 2002-07-24 2003-07-01 Antiperspirant aerosol compositions Ceased AU2003249933B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0217256.7A GB0217256D0 (en) 2002-07-24 2002-07-24 Antiperspirant aerosol compositions
GB0217256.7 2002-07-24
PCT/EP2003/007065 WO2004014330A1 (en) 2002-07-24 2003-07-01 Antiperspirant aerosol compositions

Publications (2)

Publication Number Publication Date
AU2003249933A1 true AU2003249933A1 (en) 2004-02-25
AU2003249933B2 AU2003249933B2 (en) 2006-07-27

Family

ID=9941089

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003249933A Ceased AU2003249933B2 (en) 2002-07-24 2003-07-01 Antiperspirant aerosol compositions

Country Status (12)

Country Link
US (1) US20060104918A1 (en)
EP (1) EP1531788B1 (en)
JP (1) JP2006502130A (en)
AT (1) ATE353007T1 (en)
AU (1) AU2003249933B2 (en)
BR (1) BR0312193A (en)
DE (1) DE60311583T2 (en)
ES (1) ES2279978T3 (en)
GB (1) GB0217256D0 (en)
MX (1) MXPA05000986A (en)
WO (1) WO2004014330A1 (en)
ZA (1) ZA200410050B (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1909916B1 (en) * 2005-07-30 2009-05-27 Unilever PLC Anhydrous spray compositions containing a particulate antiperspirant active and a moisturising agent
DE102009048555B4 (en) 2009-10-07 2011-12-22 Beiersdorf Ag Use of sprayable preparations with a high proportion of propellant gas
DE102010063754A1 (en) * 2010-12-21 2012-06-21 Beiersdorf Ag Aerosol formulations with improved spray properties
BR112015004185B1 (en) * 2012-09-14 2020-09-15 The Procter & Gamble Company ANTIPERSPIRANT COMPOSITIONS IN AEROSOL AND PRODUCTS
US20150023886A1 (en) * 2013-07-16 2015-01-22 The Procter & Gamble Company Antiperspirant Spray Devices and Compositions
US11186424B2 (en) 2013-07-16 2021-11-30 The Procter & Gamble Company Antiperspirant spray devices and compositions
US10787283B2 (en) * 2013-07-16 2020-09-29 The Procter & Gamble Company Antiperspirant spray devices and compositions
US10766646B2 (en) 2013-07-16 2020-09-08 The Procter & Gamble Company Antiperspirant spray devices and compositions
FR3015260B1 (en) * 2013-12-19 2018-08-31 L'oreal ANTI-TRANSPARENT ANHYDROUS COMPOSITION IN THE FORM OF AEROSOL COMPRISING AN ANTI-TRANSPARENT ACTIVE INGREDIENT AND A NON-WATER-SOLUBLE FILMOGENIC ETHYLENE POLYMER AND SEQUENCE
US9662285B2 (en) 2014-03-13 2017-05-30 The Procter & Gamble Company Aerosol antiperspirant compositions, products and methods
US9579265B2 (en) * 2014-03-13 2017-02-28 The Procter & Gamble Company Aerosol antiperspirant compositions, products and methods
US9572758B2 (en) 2015-06-30 2017-02-21 Gulbrandsen Technologies, Inc. Method of making high performance activated aluminum sesquichlorohydrate powders
US11058616B2 (en) 2017-12-18 2021-07-13 The Procter & Gamble Company Aerosol antiperspirant methods

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1485373A (en) * 1973-11-08 1977-09-08 Unilever Nv Antiperspirant composition
US4152416A (en) * 1976-09-17 1979-05-01 Marra Dorothea C Aerosol antiperspirant compositions delivering astringent salt with low mistiness and dustiness
US4904463A (en) * 1988-03-22 1990-02-27 The Procter & Gamble Company Aerosol antiperspirant compositions
GB9604340D0 (en) * 1996-02-29 1996-05-01 Unilever Plc Antiperspirant aerosol composition and method of making same
GB9606901D0 (en) * 1996-04-02 1996-06-05 Unilever Plc Topical composition
GB2314021A (en) * 1996-06-14 1997-12-17 Unilever Plc Skin cooling anti-perspirant aerosol compositions
AU709124B2 (en) * 1996-06-28 1999-08-19 Unilever Plc Antiperspirant/deodorant fluid composition
GB9703261D0 (en) * 1997-02-17 1997-04-09 Unilever Plc Antiperspirant composition
GB9819366D0 (en) * 1998-09-04 1998-10-28 Unilever Plc Antiperspirant material and compositions containing it
GB9819991D0 (en) * 1998-09-14 1998-11-04 Unilever Plc Antiperspirant composition and method
US5976514A (en) * 1998-11-20 1999-11-02 Procter & Gamble Company Low-irritation antiperspirant and deodorant compositions containing a volatile, nonpolar hydrocarbon liquid
GB0019055D0 (en) * 2000-08-03 2000-09-27 Unilever Plc Antiperspirant and deodorant products and methods for their use
US6468512B1 (en) * 2000-11-22 2002-10-22 Avon Products, Inc. Gel compositions
GB0100549D0 (en) * 2001-01-09 2001-02-21 Unilever Plc Antiperspirant or deodorant compositions
GB0104268D0 (en) * 2001-02-21 2001-04-11 Unilever Plc Antiperspirant or deodorant compositions

Also Published As

Publication number Publication date
ZA200410050B (en) 2006-07-26
ATE353007T1 (en) 2007-02-15
EP1531788B1 (en) 2007-01-31
BR0312193A (en) 2005-04-26
AU2003249933B2 (en) 2006-07-27
DE60311583D1 (en) 2007-03-22
WO2004014330A1 (en) 2004-02-19
JP2006502130A (en) 2006-01-19
US20060104918A1 (en) 2006-05-18
GB0217256D0 (en) 2002-09-04
MXPA05000986A (en) 2005-05-16
EP1531788A1 (en) 2005-05-25
ES2279978T3 (en) 2007-09-01
DE60311583T2 (en) 2007-05-24

Similar Documents

Publication Publication Date Title
US8518384B2 (en) Spray compositions
EP1814505B1 (en) Underarm cosmetic method
EP2189149B1 (en) Antiperspirant compositions
US5840289A (en) Antiperspirant aerosol composition and method of making same
AU2003249933B2 (en) Antiperspirant aerosol compositions
EP0024176A2 (en) Composition for inhibiting axillary odour
EP0024175A2 (en) Composition and process for reducing axillary odour
MXPA97001376A (en) Composition of antitranspirant aerosol and method for factory
ES2372175T3 (en) ANTITRANSPIRING COMPOSITIONS CONTAINING VASELINE.
MXPA01002278A (en) Antiperspirant material and compositions containing it.
WO1994024993A1 (en) Antiperspirant compositions
AU2003206906A1 (en) Antiperspirant or deodorant composition
JP3920785B2 (en) Powder-containing cosmetic
GB2072503A (en) Antiperspirant compositions
MXPA05001186A (en) Fabric conditioning compositions.
US5985252A (en) Cosmetic composition
US11998624B2 (en) Anhydrous antiperspirant aerosol composition
JP3035632B2 (en) Powder aerosol cosmetics
EA032891B1 (en) Antiperspirant compositions comprising alums
JPH0579642B2 (en)

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired